Wikidata

(Q46906455)

English

Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes.

scientific article published in January 2005

In more languages

Statements

title
Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes. (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
16430196
retrieved
26 December 2017
reference URL
http://europepmc.org/abstract/MED/16430196

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q46906455&oldid=1338671029"